HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment results of image-guided high-dose-rate interstitial brachytherapy for pelvic recurrence of uterine cancer.

AbstractPURPOSE:
We analyzed clinical data to evaluate the effectiveness of image-guided high-dose-rate interstitial brachytherapy (HDR-ISBT) for pelvic recurrence of uterine cancer.
METHODS AND MATERIALS:
Between 2003 and 2011, 56 patients were treated with HDR-ISBT with or without external beam radiotherapy (EBRT). The median followup time was 33 months (range, 1-109 months). Pre-ISBT treatments included radical hysterectomy for 35 patients (Group A), radical hysterectomy with postoperative radiotherapy for 8 patients (Group B), and radical radiotherapy for 13 patients (Group C). We initiated MRI-assisted CT-based planning for the last 49 patients. The median ISBT single fraction dose was 6 Gy. The median total doses were 30 and 54 Gy with and without EBRT (range, 30-50 Gy) for Group A, respectively and 48 Gy without EBRT for Groups B and C.
RESULTS:
The 3-year local control (LC) rates were 85%, 75%, and 46% for Groups A, B, and C, respectively (p = 0.017). The 3-year LC rates were 84%, 73%, and 33% for clinical target volume at the time of HDR-ISBT of <10, 10-29, and ≥30 cc, respectively (p = 0.005). The 3-year LC results tended to be higher for patients whose D100 (clinical target volume) was equal or higher than 67.1 Gy (p = 0.098). A total of 13 late complications of Grades 3-5 occurred in 11 patients (20%).
CONCLUSIONS:
Our image-guided HDR-ISBT for pelvic recurrence of uterine cancer provided good treatment outcomes. The treatment results for patients who underwent radical surgery with or without postoperative radiotherapy are better than those for patients who underwent radical radiotherapy.
AuthorsKen Yoshida, Hideya Yamazaki, Tadayuki Kotsuma, Tadashi Takenaka, Koji Masui, Yasuo Yoshioka, Yasuo Uesugi, Taiju Shimbo, Nobuhiko Yoshikawa, Hiroto Yoshioka, Yoshifumi Narumi, Keiji Tatsumi, Eiichi Tanaka
JournalBrachytherapy (Brachytherapy) 2015 Jul-Aug Vol. 14 Issue 4 Pg. 440-8 ISSN: 1873-1449 [Electronic] United States
PMID25858904 (Publication Type: Evaluation Study, Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2015 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Brachytherapy (adverse effects, methods)
  • Combined Modality Therapy
  • Female
  • Follow-Up Studies
  • Humans
  • Hysterectomy (methods)
  • Magnetic Resonance Imaging
  • Magnetic Resonance Imaging, Interventional (methods)
  • Middle Aged
  • Neoplasm Recurrence, Local (radiotherapy)
  • Radiotherapy Dosage
  • Radiotherapy Planning, Computer-Assisted (methods)
  • Tomography, X-Ray Computed
  • Treatment Outcome
  • Uterine Neoplasms (therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: